Embryonic and induced pluripotent stem cells as a model for liver disease

Hiroshi Yagi, Edgar Tafaleng, Masaki Nagaya, Marc C. Hansel, Stephen C. Strom, Ira J. Fox, Alejandro Soto-Gutierrez

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Induced pluripotent stem (iPS) cells are human somatic cells that have been reprogrammed to a pluripotent state. Through several elegant technologies, we are now able to generate human iPS cells with disease genotypes that could serve as invaluable tools for human disease modeling. This could lead to an understanding of the root causes of a disease and to the development of effective prophylactic and therapeutic strategies for it. However, we are still far from generating fully functional liver cells from stem cells, including iPS cells, on in vitro culture systems. Tissue-engineering techniques have opened the window to inducing a functional fate for differentiated cells by providing a microenvironment that allows the maintenance of signals similar to those found in the natural microenvironment. Here we review the current technology to establish iPS cells and discuss strategies to generate human liver disease modeling using iPS cell technology in concert with bioengineering approaches.

Original languageEnglish
Pages (from-to)377-398
Number of pages22
JournalCritical Reviews in Biomedical Engineering
Volume37
Issue number4-5
Publication statusPublished - 2009

Fingerprint

Stem cells
Liver
Tissue engineering
Cell culture

Keywords

  • Decellularized liver
  • Embryonic stem cell
  • Extracellular matrix and differentiation
  • Induced pluripotent stem cell

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Yagi, H., Tafaleng, E., Nagaya, M., Hansel, M. C., Strom, S. C., Fox, I. J., & Soto-Gutierrez, A. (2009). Embryonic and induced pluripotent stem cells as a model for liver disease. Critical Reviews in Biomedical Engineering, 37(4-5), 377-398.

Embryonic and induced pluripotent stem cells as a model for liver disease. / Yagi, Hiroshi; Tafaleng, Edgar; Nagaya, Masaki; Hansel, Marc C.; Strom, Stephen C.; Fox, Ira J.; Soto-Gutierrez, Alejandro.

In: Critical Reviews in Biomedical Engineering, Vol. 37, No. 4-5, 2009, p. 377-398.

Research output: Contribution to journalArticle

Yagi, H, Tafaleng, E, Nagaya, M, Hansel, MC, Strom, SC, Fox, IJ & Soto-Gutierrez, A 2009, 'Embryonic and induced pluripotent stem cells as a model for liver disease', Critical Reviews in Biomedical Engineering, vol. 37, no. 4-5, pp. 377-398.
Yagi H, Tafaleng E, Nagaya M, Hansel MC, Strom SC, Fox IJ et al. Embryonic and induced pluripotent stem cells as a model for liver disease. Critical Reviews in Biomedical Engineering. 2009;37(4-5):377-398.
Yagi, Hiroshi ; Tafaleng, Edgar ; Nagaya, Masaki ; Hansel, Marc C. ; Strom, Stephen C. ; Fox, Ira J. ; Soto-Gutierrez, Alejandro. / Embryonic and induced pluripotent stem cells as a model for liver disease. In: Critical Reviews in Biomedical Engineering. 2009 ; Vol. 37, No. 4-5. pp. 377-398.
@article{7a517b72cad04f6e8211c0973fab84ab,
title = "Embryonic and induced pluripotent stem cells as a model for liver disease",
abstract = "Induced pluripotent stem (iPS) cells are human somatic cells that have been reprogrammed to a pluripotent state. Through several elegant technologies, we are now able to generate human iPS cells with disease genotypes that could serve as invaluable tools for human disease modeling. This could lead to an understanding of the root causes of a disease and to the development of effective prophylactic and therapeutic strategies for it. However, we are still far from generating fully functional liver cells from stem cells, including iPS cells, on in vitro culture systems. Tissue-engineering techniques have opened the window to inducing a functional fate for differentiated cells by providing a microenvironment that allows the maintenance of signals similar to those found in the natural microenvironment. Here we review the current technology to establish iPS cells and discuss strategies to generate human liver disease modeling using iPS cell technology in concert with bioengineering approaches.",
keywords = "Decellularized liver, Embryonic stem cell, Extracellular matrix and differentiation, Induced pluripotent stem cell",
author = "Hiroshi Yagi and Edgar Tafaleng and Masaki Nagaya and Hansel, {Marc C.} and Strom, {Stephen C.} and Fox, {Ira J.} and Alejandro Soto-Gutierrez",
year = "2009",
language = "English",
volume = "37",
pages = "377--398",
journal = "Critical Reviews in Biomedical Engineering",
issn = "0278-940X",
publisher = "Begell House Inc.",
number = "4-5",

}

TY - JOUR

T1 - Embryonic and induced pluripotent stem cells as a model for liver disease

AU - Yagi, Hiroshi

AU - Tafaleng, Edgar

AU - Nagaya, Masaki

AU - Hansel, Marc C.

AU - Strom, Stephen C.

AU - Fox, Ira J.

AU - Soto-Gutierrez, Alejandro

PY - 2009

Y1 - 2009

N2 - Induced pluripotent stem (iPS) cells are human somatic cells that have been reprogrammed to a pluripotent state. Through several elegant technologies, we are now able to generate human iPS cells with disease genotypes that could serve as invaluable tools for human disease modeling. This could lead to an understanding of the root causes of a disease and to the development of effective prophylactic and therapeutic strategies for it. However, we are still far from generating fully functional liver cells from stem cells, including iPS cells, on in vitro culture systems. Tissue-engineering techniques have opened the window to inducing a functional fate for differentiated cells by providing a microenvironment that allows the maintenance of signals similar to those found in the natural microenvironment. Here we review the current technology to establish iPS cells and discuss strategies to generate human liver disease modeling using iPS cell technology in concert with bioengineering approaches.

AB - Induced pluripotent stem (iPS) cells are human somatic cells that have been reprogrammed to a pluripotent state. Through several elegant technologies, we are now able to generate human iPS cells with disease genotypes that could serve as invaluable tools for human disease modeling. This could lead to an understanding of the root causes of a disease and to the development of effective prophylactic and therapeutic strategies for it. However, we are still far from generating fully functional liver cells from stem cells, including iPS cells, on in vitro culture systems. Tissue-engineering techniques have opened the window to inducing a functional fate for differentiated cells by providing a microenvironment that allows the maintenance of signals similar to those found in the natural microenvironment. Here we review the current technology to establish iPS cells and discuss strategies to generate human liver disease modeling using iPS cell technology in concert with bioengineering approaches.

KW - Decellularized liver

KW - Embryonic stem cell

KW - Extracellular matrix and differentiation

KW - Induced pluripotent stem cell

UR - http://www.scopus.com/inward/record.url?scp=77952150625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952150625&partnerID=8YFLogxK

M3 - Article

C2 - 20528732

AN - SCOPUS:77952150625

VL - 37

SP - 377

EP - 398

JO - Critical Reviews in Biomedical Engineering

JF - Critical Reviews in Biomedical Engineering

SN - 0278-940X

IS - 4-5

ER -